[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361478-105":59,"doc-detail-361478-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microrna-181a-5p-promotes-papillary-thyroid-carcinoma-progress-via-the-ptenakt-pathway","MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway","","This investigation determined the expression profile and latent mechanism of microRNA-181a-5p (miR-181a-5p) in the genesis and progression of papillary thyroid cancer (PTC). miR-181a-5p was upregulated in PTC tissues and cells, and its level in patients correlated with tumor size and thyroid capsule invasion. Functional assays showed enhanced proliferation, motility, and invasion after miR-181a-5p upregulation, while inhibition suppressed these behaviors. Mechanistically, miR-181a-5p reduced PTEN and increased phosphorylated AKT activity via direct targeting of the PTEN 3'UTR, supporting a PTEN/Akt-driven progression model.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microrna-181a-5p-promotes-papillary-thyroid-carcinoma-progress-via-the-ptenakt-pathway/361478/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microrna-181a-5p-promotes-papillary-thyroid-carcinoma-progress-via-the-ptenakt-pathway/361478.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of the study on miR-181a-5p in papillary thyroid cancer?","Question",{"text":112,"@type":113},"To determine the expression profile of miR-181a-5p and elucidate its underlying mechanism in the genesis and progression of PTC, including its clinicopathological implications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does miR-181a-5p expression relate to clinical features of PTC patients?",{"text":117,"@type":113},"miR-181a-5p was upregulated in PTC tissues and cells, and in PTC patients its level was linked to tumor size and thyroid capsule invasion.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism did the study propose for miR-181a-5p promoting PTC progression?",{"text":121,"@type":113},"miR-181a-5p suppresses PTEN expression, enhances phosphorylated AKT (P-AKT) activation, and is predicted to target a binding site on the PTEN 3'UTR, indicating a PTEN/Akt pathway involvement.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361478,1790193335,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Molecular Biotechnology (2026) 68:3715–3726  \n[https://doi.org/10.1007/s12033-026-01581-2](https://doi.org/10.1007/s12033-026-01581-2)  \nMicroRNA‑181a‑5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway  \nWenyu Zhao1,2 · Yiting Guo1 · Liang He3 · Junhong Li4 · Zhenglun Qiu3 · Haojie Chen5 · Leilei Li3 · Hua Wang6 · Yunlong Wang7 · Yanfang Zhang1,7  \nReceived: 8 September 2023 / Accepted: 6 May 2026 / Published online: 3 June 2026 © The Author(s) 2026  \nAbstract  \nThe objective of this investigation was to determine the expression profile and latent mechanism of microRNA-181a-5p (miR- 181a-5p) in the genesis and progression of papillary thyroid cancer (PTC). MiR-181a-5p was discovered to be upregulated in PTC tissues and cells in this study, as confirmed by RT‒qPCR and The Cancer Genome Atlas database. Notably, in PTC patients, the miR-181a-5p level was linked to tumor size and thyroid capsule invasion. A series of experiments demonstrated that miR-181a-5p upregulation in PTC cells notably enhanced proliferation, motility, and invasion, whereas suppressing miR-181a-5p hindered these functions. Western blotting revealed that miR-181a-5p suppressed PTEN expression, boosting the activation of phosphorylated AKT (P-AKT) . According to predictive bioinformatics research and luciferase reporter gene tests, miR-181a-5p may target a specific binding site on the PTEN 3'UTR. To sum up, this study indicated that miR- 181a-5p promoted PTC progression through the PTEN/Akt pathway. This investigation reveals a potential mechanism for PTC progression and provides a foundation for clinical therapies.  \nKeywords Papillary thyroid cancer · MiR-181a-5p · PTEN · PTEN/Akt pathway · Biomarker  \n* Yanfang Zhang [yanfangz@zzu.edu.cn](yanfangz@zzu.edu.cn)  \n1 Department of Endocrinology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan Province, People’s Republic of China  \n2 Zhengzhou University, Zhengzhou 450001, Henan Province, China  \n3 Department of Thyroid and Breast Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan Province, China  \n4 Department of Pathology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan Province, China  \n5 Department of Cardiology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan Province, China  \n6 Department of Ultrasound, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan Province, China  \n7 Zhongyuan Scholars Workstation of Henan, Luoyang 471000, Henan Province, China  \nIntroduction  \nIn the past few years, there has been a notable increase in the occurrence of thyroid cancer (TC) [1]. Papillary thyroid carcinoma (PTC) is the predominant histologic form of cancer, accounting for approximately 85% to 90% of thyroid cancer cases [2] . Although the majority of PTCs have a favorable prognosis, a certain percentage of PTCs still exhibit significant progression to secondary metastasis, leading to a poor outcome [3] . The greatest clinical challenge in identifying PTCs lies in accurately diagnosing them. Ultrasound diagnosis relies heavily on the examiner's experience and knowledge. Fine needle aspiration biopsy (FNAB) is also limited because it screens only a small volume of tissue and cellular components and may not fully represent the nature of the lesion [4]. Approximately 15%−30% of lesions cannot be diagnosed [5]. Molecular testing can enhance diagnostic accuracy by identifying patients with uncertain cytology as PTCs [6] . Hence, it is paramount to uncover the molecular mechanisms underpinning PTC to identify more potent therapeutic targets for managing this disease.  \nMicroRNAs (miRNAs) are small, noncoding RNAs that influence gene expression in a variety of ways, ranging from  \n19 to 25 nucleotides in length [7]. According to a substantial body of research, miRNAs may be involved in a number of cancers, including carcinogene","cbCaimjioU89UOy3","https://ap.wps.com/l/cbCaimjioU89UOy3","pdf",4130927,12,"English","# Abstract\n## Objective and approach\n## Key findings: expression and clinical correlations\n## Mechanism: PTEN/AKT axis and PTEN 3'UTR targeting\n## Significance for therapy\n# Introduction\n## Burden and diagnostic challenges in PTC\n## Role of microRNAs in cancer and potential as biomarkers\n## Prior evidence and knowledge gap for miR-181a-5p in PTC\n## Study purpose\n# Materials and methods\n## Tissue samples","[{\"question\":\"What was the main aim of the study on miR-181a-5p in papillary thyroid cancer?\",\"answer\":\"To determine the expression profile of miR-181a-5p and elucidate its underlying mechanism in the genesis and progression of PTC, including its clinicopathological implications.\"},{\"question\":\"How does miR-181a-5p expression relate to clinical features of PTC patients?\",\"answer\":\"miR-181a-5p was upregulated in PTC tissues and cells, and in PTC patients its level was linked to tumor size and thyroid capsule invasion.\"},{\"question\":\"What mechanism did the study propose for miR-181a-5p promoting PTC progression?\",\"answer\":\"miR-181a-5p suppresses PTEN expression, enhances phosphorylated AKT (P-AKT) activation, and is predicted to target a binding site on the PTEN 3'UTR, indicating a PTEN/Akt pathway involvement.\"}]","MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway | PDF",1790144457,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c2f0ca455a93676cc1cfdb4229ee426.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f40a5043a1925886aeec759a8915232e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8570d5403868256589adbf60fd4cf8c.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3813917971d112716460af08a4f513a3.webp",980,1301]